As the saying goes, breakfast is the most important meal of the day, and according to new research presented at the annual meeting of the European Association for the Study of Diabetes (EASD), this may indeed be the case — at least as far as people with Type 2 diabetes are concerned.
September, this final month of summer-turned-autumn, was a busy one for our Diabetes Online Community, and it brought some truly great posts and advocacy initiatives from all corners
The device includes an insulin pump and a glucose sensor that stops insulin delivery when blood glucose reaches a preset level. The system has been approved for use by diabetics aged 16 years and older. Medtronic said it would conduct a post-approval study that would include children aged 2 years and older.
By 2014 every American, with some very few exceptions, will have to have some form of health insurance or be fined. The idea is that more healthy people will buy insurance, and the money the insurance companies save on them will cover the costs of insuring the older and sicker people who will now be […]
These much-anticipated mHealth guidelines come a full 27 months after the FDA issued draft guidelines and welcomed public comment, meaning the agency has spent a little over two years compiling extensive examples and finalizing the document for public release
While it may be the last thing you want to guzzle down with meals, vinegar can help diabetics gain better control over blood sugar levels, reports a new study in the Journal of Functional Foods.
From Consumer Reports, customer reviews, articles like this one in Diabetes Forecast, and comments on diabetes blogs, it seems like most meters and strips have pretty similar quality. So how do you choose?
A new systematic review of published studies suggests when prescribing antidepressant medication, clinicians should be extra aware that they are linked to raised risk for type 2 diabetes, although the study does not suggest the drugs are the direct cause.
The prospect of undergoing surgery can be unnerving, leaving you feeling overwhelmed and vulnerable. A million questions could be running through your head: What if something goes wrong? How long will it take me to recover? Is it worth doing it at all?
If you’ve been reading about gestational diabetes over the past couple of weeks, you might be thinking that it seems like an awful lot of work to manage it. You’re right, it is. Remember that gestational diabetes is diabetes that occurs during pregnancy.
Everything new is good, so here is a rundown of what I’ve found to be good, bad and ugly on the three new devices: the Dexcom G4, t:slim insulin pump, and Bayer Contour NEXT fingerstick meter.
The investigational glucagon-like peptide-1, once-weekly dulaglutide, appears to control diabetes in relatively recently diagnosed patients better than daily metformin monotherapy, researchers reported here.
“We know that improving diets tends to be hard, but adding a single food is easy,” explained Dr. David Katz, Director of the Yale-Griffin Prevention Research Center and lead author of the research team. “Our theory is that if a highly nutritious, satiating food like walnuts is added to the diet, there are dual benefits: […]
Alefacept (sold as Amevive) was used to treat the skin disorder psoriasis in the US before it was withdrawn by its manufacturer in 2011. The drug was never approved for the European drug market.Psoriasis, like type 1 diabetes, is an autoimmune disorder that occurs when the immune system attacks healthy skin cells.
For those new to the wacky world of diabetes, back in 2006 Bayer acquired privately held Metrika, the makers of the A1CNow. Back in the day the A1CNow was the only at home A1C test on the market and the acquisition was generally viewed as a positive step for Bayer.
Is there anything to the myth of cholesterol levels being connected to how many eggs you eat? And statins seem so confusing, what do they do for us?
In a recently published study, researchers aimed to examine the effects acute sleep deprivation has on food purchasing choices in a “mock supermarket.”
The nifty ratio – weight divided by the square of height – was invented in the mid-1800s by Belgian social scientist Adolphe Quetelet. But its use as an indicator of obesity-related health risks dates to a 1972 journal article by American scientist Ancel Keys, the man who renamed it.
According to Bayer, which co-developed the drug along with Regeneron, the drug VEGF Trap-Eye, also known as Eylea, has reached goals established by the companies during year-long, Phase 3 trials.
The drug of choice to treat type 2 diabetes may have uses beyond the treatment of diabetes alone, according to the results a new study.